002390.SZ · 信邦制药
China A-shares · RS rating 67 · As of 2026-10-14
| Price | 2.90 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 60 / 68 / 46 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 22 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.7% |
| Distance from 52-week high | +30.1% |
| Market cap (USD) | $875.0M |